Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
Prevention of rejection after renal transplantation requires treatment with immunosuppressive drugs. Data on their in vivo effects on T- and B-cell phenotype and function are limited.In a randomized double-blind placebo-controlled study to prevent renal allograft rejection, patients were treated wit...
Main Authors: | Elena G Kamburova, Hans J P M Koenen, Martijn W F van den Hoogen, Marije C Baas, Irma Joosten, Luuk B Hilbrands |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4231065?pdf=render |
Similar Items
-
Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.
by: Ellen Kreijveld, et al.
Published: (2008-01-01) -
Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy.
by: Jorieke H Peters, et al.
Published: (2008-01-01) -
De novo isolated gastrointestinal tract vasculitis without associated systemic disease in renal transplant recipients successfully treated with rituximab
by: Cigdem Mengus, et al.
Published: (2020-01-01) -
Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation.
by: Jorieke H Peters, et al.
Published: (2008-01-01) -
Treatment of Recurrent Focal Segmental Glomerulosclerosis
in Pediatric Kidney Transplant Recipients: Effect of Rituximab
by: Christine Sethna, et al.
Published: (2011-01-01)